4
Changes in Ownership
Nuvectis Pharma, Inc. Filed Acc 0001104659-23-081834
Chairman & CEO bought 260 shares at an average $15.52 ($4,035)
From the SEC's structured data for this filing
Trades in this filing
BENTSUR RON · Chairman & CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-07-07 | Purchase : show line 1 in the form | +110 | $16.19 | $1,781 | 3,231,209 | D |
| 2023-07-14 | Purchase : show line 2 in the form | +150 | $15.03 | $2,255 | 3,231,359 | D |
| Open-market purchases · 260 sh · avg $15.52 · $4,035 | ||||||
Loading xslF345X05/tm2321526-1_4seq1.xml…